Atlas Trials

Effects of Intravenous Metabolic Recovery Agent in Elderly Septic Patients on Prognosis and Microcirculation.

Clinical trial NCT06723626 · RECRUITING

Trial details

NCT number
NCT06723626
Sponsor
Southeast University, China
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Septic Shock
Start date
2024-07-01
Primary completion
2025-11-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.